Community-based interventions to improve prostate cancer screening and implications for black men: a scoping review
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20253713Keywords:
PSA, DRE, Community, Interventions, Black, MenAbstract
The role of early detection of prostate cancer through prostate specific antigen (PSA) testing with or without digital rectal examination (DRE) to improve prostate cancer outcomes remains contentious, with ongoing debates about benefits and risks. Despite limitations, PSA testing with or without DRE remains the mainstay of early prostate cancer detection. Still, research findings have demonstrated underutilisation among black men who are most at risk. In this scoping literature review, three databases (PubMed NLM, CINAHL, and PsycINFO) were searched to identify and characterise community-based interventions to promote early detection of prostate cancer. Review studies, systematic or not, were excluded as well as studies that were not published in English, nor focused mainly on prostate cancer. Fifteen studies met the search criteria and were included in the review, with only one published in the UK, one in Iran, and 13 in the USA. The authors utilised community engagement strategies with faith-based groups, especially churches, making key contributions within American society. Decision aid tools to help men overcome their decisional conflicts and navigate to the point of screening were an important feature of many of the studies. Our findings suggest that well-designed and carefully tailored community-based interventions could contribute to creating awareness and informed decisions for PSA testing with or without DRE. In the UK society, such interventions are still required and should be prioritised without delay to help improve early prostate cancer detection among black men.
Metrics
References
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A, Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2024;74(3):229-63. DOI: https://doi.org/10.3322/caac.21834
Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol. 2020;77(1):38-52. DOI: https://doi.org/10.1016/j.eururo.2019.08.005
Wong MC, Goggins WB, Wang HH, Fung FD, Leung C, Wong SY, et al. Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries. Eur Urol. 2016;70(5):862-74. DOI: https://doi.org/10.1016/j.eururo.2016.05.043
Tangirala K, Appukkuttan S, Simmons S. Costs and healthcare resource utilization associated with hospital admissions of patients with metastatic or nonmetastatic prostate cancer. Am Health Drug Benefits. 2019;12(6):306.
Roehrborn CG, Black LK. The economic burden of prostate cancer. BJU Int. 2011;108(6):806-13. DOI: https://doi.org/10.1111/j.1464-410X.2011.10365.x
Tan EH, Burn E, Barclay NL, Delmestri A, Man WY, Golozar A, et al. Incidence, Prevalence, and Survival of Prostate Cancer in the UK. JAMA Network Open. 2024;7(9):e2434622. DOI: https://doi.org/10.1001/jamanetworkopen.2024.34622
Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, et al. The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study. Eur Urol. 2008;53(1):99-105. DOI: https://doi.org/10.1016/j.eururo.2007.02.047
Odedina FT, Akinremi TO, Chinegwundoh F, Roberts R, Yu D, Reams RR, et al. Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agents Cancer. 2009;4(1):S2. DOI: https://doi.org/10.1186/1750-9378-4-S1-S2
Taitt HE. Global Trends and Prostate Cancer: A Review of Incidence, Detection, and Mortality as Influenced by Race, Ethnicity, and Geographic Location. Am J Men's Health. 2018;12(6):1807-23. DOI: https://doi.org/10.1177/1557988318798279
Lloyd T, Hounsome L, Mehay A, Mee S, Verne J, Cooper A. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008-2010. BMC Med. 2015;13(1):171. DOI: https://doi.org/10.1186/s12916-015-0405-5
Hinata N, Fujisawa M. Racial Differences in Prostate Cancer Characteristics and Cancer-Specific Mortality: An Overview. World J Mens Health. 2022;40(2):217-27. DOI: https://doi.org/10.5534/wjmh.210070
Fletcher SA, Marchese M, Cole AP, Mahal BA, Friedlander DF, Krimphove M, et al. Geographic Distribution of Racial Differences in Prostate Cancer Mortality. JAMA Network Open. 2020;3(3):e201839-. DOI: https://doi.org/10.1001/jamanetworkopen.2020.1839
Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4(6):877-92. DOI: https://doi.org/10.1016/j.euo.2021.09.006
Cirne F, Kappel C, Zhou S, Mukherjee SD, Dehghan M, Petropoulos JA, et al. Modifiable risk factors for prostate cancer in low-and lower-middle-income countries: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2022;25(3):453-62. DOI: https://doi.org/10.1038/s41391-022-00570-1
Andriole GL, Crawford ED, Grubb III RL, Buys SS, Chia D, Church TR, et al. Mortality results from a randomized prostate-cancer screening trial. N Eng J Med. 2009;360(13):1310-9. DOI: https://doi.org/10.1056/NEJMoa0810696
Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018;362:k3519. DOI: https://doi.org/10.1136/bmj.k3519
Djulbegovic M, Beyth RJ, Neuberger MM, Stoffs TL, Vieweg J, Djulbegovic B, et al. Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ. 2010;341:c4543. DOI: https://doi.org/10.1136/bmj.c4543
US Preventive Services Task Force, Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(18):1901-13. DOI: https://doi.org/10.1001/jama.2018.3710
Bradley SH, Funston G, Jones D, Watson J. Diagnosing prostate cancer in asymptomatic patients. BMJ. 2022;377:e071076. DOI: https://doi.org/10.1136/bmj-2022-071076
Shungu N, Sterba KR. Barriers and Facilitators to Informed Decision-Making About Prostate Cancer Screening Among Black Men. J Am Board Fam Med. 2021;34(5):925-36. DOI: https://doi.org/10.3122/jabfm.2021.05.210149
Alexis O, Worsley A. An integrative review exploring black men of African and Caribbean backgrounds, their fears of prostate cancer and their attitudes towards screening. Health Educat Res. 2018;33(2):155-66. DOI: https://doi.org/10.1093/her/cyy001
Lopez A, Bailey JT, Galloway D, Woods-Burnham L, Montgomery SB, Kittles R, et al. Evidence-based Prostate Cancer Screening Interventions for Black Men: A Systematic Review. J Racial Ethnic Health Disparities. 2024;10:1-9
Benedict MO, Steinberg WJ, Claassen FM, Mofolo N. Enhancing public awareness and practice of prostate cancer screening among African men: A scoping review. S Afr Family Pract. 2023;65(1):1-11. DOI: https://doi.org/10.4102/safp.v65i1.5621
Cook DA. Systematic and nonsystematic reviews: choosing an approach. Healthcare simulation research: A practical guide. 2019;55-60. DOI: https://doi.org/10.1007/978-3-030-26837-4_8
Ba DM, Kayembe C, Littlejohn J, Van Scoy LJ, VanDyke E, Williams J, et al. Navigation-Based Telehealth Informed Decision-Making for Prostate Cancer Screening in Black Men. Curr Oncol. 2024;31(7):3698-712. DOI: https://doi.org/10.3390/curroncol31070273
Allen JD, Reich A, Cuevas AG, Ladin K. Preparing African American Men to Make Informed Prostate Cancer Screening Decisions: Development and Pilot Testing of an Interactive Online Decision Aid. JMIR Mhealth Uhealth. 2020;8(5):e15502. DOI: https://doi.org/10.2196/15502
Wray RJ, Nicks SE, Adsul P, Elliot M, Enard K, Jupka K, et al. Promoting informed prostate cancer screening decision-making for African American men in a community-based setting. Cancer Causes Control. 2022;33(4):503-14. DOI: https://doi.org/10.1007/s10552-021-01544-9
Frencher S, Sharma A, Teklehaimanot S, Wadzani D, Ike I, Hart A, et al. PEP Talk: Prostate Education Program, "Cutting Through the Uncertainty of Prostate Cancer for Black Men Using Decision Support Instruments in Barbershops". J Cancer Educat. 2016;31(3):506-13. DOI: https://doi.org/10.1007/s13187-015-0871-7
Martinez-Lopez N, Makarov DV, Thomas J, Ciprut S, Hickman T, Cole H, et al. A Study to Compare a CHW-Led Versus Physician-Led Intervention for Prostate Cancer Screening Decision-Making among Black Men. Ethn Dis. 2023;33(1):26-32. DOI: https://doi.org/10.18865/1722
Carlson DS, Grivas P, Wei W, Dhillon PK, Abraksia S. The Effectiveness of Shared Compared to Informed Decision Making for Prostate Cancer Screening in a High-Risk African American Population: A Randomized Control Trial. Cancer Investigation. 2021;39(2):124-32. DOI: https://doi.org/10.1080/07357907.2020.1855441
Ashorobi OS, Frost J, Wang X, Roberson P, Lin E, Volk RJ, et al. Prostate cancer education, detection, and follow-up in a community-based multiethnic cohort of medically underserved men. Am J Men's Health. 2017;11(1):82-91. DOI: https://doi.org/10.1177/1557988315584794
Sandiford L, D'Errico EM. Facilitating Shared Decision Making About Prostate Cancer Screening Among African American Men. Oncol Nursing Forum. 2016;43(1):86-92. DOI: https://doi.org/10.1188/16.ONF.86-92
Cho D, Gor B, Hwang H, Wang X, Hernandez M, Jones LA, et al. A Community-Based Prostate Cancer Screening and Education Program for Asian American Men in Medically Underserved Communities. Int J Environ Res Public Health. 2024;21(4):415. DOI: https://doi.org/10.3390/ijerph21040415
Holt CL, Le D, Slade JL, Muwwakkil B, Saunders DR, Williams R, et al. Can Women Facilitate Men’s Prostate Cancer Screening Informed Decision-Making? The M-PACT Trial. J Health Communicat. 2017;22(12):964-73. DOI: https://doi.org/10.1080/10810730.2017.1382616
Owens OL, Felder T, Tavakoli AS, Revels AA, Friedman DB, Hughes-Halbert C, et al. Evaluation of a Computer-Based Decision Aid for Promoting Informed Prostate Cancer Screening Decisions Among African American Men: iDecide. Am J Health Promot. 2019;33(2):267-78. DOI: https://doi.org/10.1177/0890117118786866
Dhillon P, Grivas P, Hobbs B, Carlson DS, Abraksia S. Education and informed decision making for prostate cancer screening in a high risk African American community. Int Clin Med. 2019;3:1-6. DOI: https://doi.org/10.15761/ICM.1000146
Roussi P, Miller SM, Giri VN, Obeid E, Wen KY, Tagai EK, et al. Effects of a randomized trial comparing standard and enhanced counseling for men at high risk of prostate cancer as a function of race and monitoring style. J Health Psychol. 2018;23(14):1800-9. DOI: https://doi.org/10.1177/1359105316671188
Molazem Z, Ebadi M, Khademian M, Zare R. Effects of an Educational Program for Prostate Cancer Prevention on knowledge and PSA Testing in Men Over 50 Years old in Community Areas of Shiraz in 2016. Asian Pacific J Cancer Prevent. 2018;19(3):633-7.
McAllister BJ, Patterson MI, Sherwood BT, Howarth JA, Malone KJ. Initial experience of a community-based prostate cancer risk assessment clinic for men of black and minority ethnicity background. Int J Urolog Nursing. 2019;13(3):106-9. DOI: https://doi.org/10.1111/ijun.12199
Rees P, Wohland P, Norman P, Boden P. Ethnic population projections for the UK, 2001-2051. J Populat Res. 2012;29:45-89. DOI: https://doi.org/10.1007/s12546-011-9076-z
Levin J. Faith-based initiatives in health promotion: history, challenges, and current partnerships. Am J Heal Promot. 2014;28(3):139-41. DOI: https://doi.org/10.4278/ajhp.130403-CIT-149
Tipre M, Hardy C, Bowman T, Glover M, Gullet P, Baity D, et al. Concept Mapping with Black Men: Barriers to Prostate Cancer Screening and Solutions. J Cancer Educ. 2023;38(6):1808-15. DOI: https://doi.org/10.1007/s13187-023-02336-2
Christie-de Jong F, Eberhardt J, Ling J, Kotzur M, Oyeniyi OS, Nnyanzi L, et al. The PROCAN-B study protocol: Early diagnosis of PROstate CANcer for Black men-a community-centred participatory approach in Scotland and the North-East of England. PLoS One. 2024;19(12):e0315288. DOI: https://doi.org/10.1371/journal.pone.0315288
Alexis O, Mansbridge S, Garbrah W. Raising awareness of prostate cancer amongst black communities in the south of England. Ethnicity Health. 2024;29(3):328-42. DOI: https://doi.org/10.1080/13557858.2024.2323465
Haider M, Scott S, Dumagat A, Lamb BW, Paparini S, Rajan P. What Are the Barriers to Early Detection of Prostate Cancer for Black Men in the UK? Trends Urol Men's Heal. 2025;16(1):e12003. DOI: https://doi.org/10.1002/tre.12003
Fry SL, Hopkinson J, Kelly D. “We're talking about black men here, there's a difference”; cultural differences in socialised knowledge of prostate cancer risk: A qualitative research study. Eur J Oncol Nursing. 2022;56:102080. DOI: https://doi.org/10.1016/j.ejon.2021.102080
Tagai EK, Scheirer MA, Santos SLZ, Haider M, Bowie J, Slade J, et al. Assessing capacity of faith-based organizations for health promotion activities. Health Promot Pract. 2018;19(5):714-23. DOI: https://doi.org/10.1177/1524839917737510
Ayton D, Manderson L, Smith BJ, Carey G. Health promotion in local churches in V ictoria: an exploratory study. Health Social Care Community. 2016;24(6):728-38. DOI: https://doi.org/10.1111/hsc.12258
Ferrari R. Writing narrative style literature reviews. Medical Writing. 2015;24(4):230-5. DOI: https://doi.org/10.1179/2047480615Z.000000000329
Downloads
Published
How to Cite
Issue
Section
